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AbstrAct
Choosing Wisely (CW) campaigns globally have focused 
attention on the need to reduce low- value care, which 
can represent up to 30% of the costs of healthcare. 
Despite early enthusiasm for the CW initiative, few 
large- scale changes in rates of low- value care have 
been reported since the launch of these campaigns. 
Recent commentaries suggest that the focus of the 
campaign should be on implementation of evidence- 
based strategies to effectively reduce low- value care. This 
paper describes the Choosing Wisely De- Implementation 
Framework (CWDIF), a novel framework that builds on 
previous work in the field of implementation science and 
proposes a comprehensive approach to systematically 
reduce low- value care in both hospital and community 
settings and advance the science of de- implementation.
The CWDIF consists of five phases: Phase 0, identification 
of potential areas of low- value healthcare; Phase 1, 
identification of local priorities for implementation of 
CW recommendations; Phase 2, identification of barriers 
to implementing CW recommendations and potential 
interventions to overcome these; Phase 3, rigorous 
evaluations of CW implementation programmes; Phase 
4, spread of effective CW implementation programmes. 
We provide a worked example of applying the CWDIF 
to develop and evaluate an implementation programme 
to reduce unnecessary preoperative testing in healthy 
patients undergoing low- risk surgeries and to further 
develop the evidence base to reduce low- value care.
IntroductIon
There is increasing recognition of the 
problem of overuse relating to ‘low- 
value care’ defined as a test or treatment 
for which there is no evidence of patient 
benefit or where there is evidence of more 
harm than benefit.1 2 The Canadian Insti-
tute f for Health Information report that 
as much as 30% of healthcare is consid-
ered low value, which can lead to poor 
patient outcomes due to adverse events 
of treatments or unwarranted secondary 
tests (with potential for overtreatment of 
incidental findings), and inefficient use of 
scarce healthcare resources threatening 
the sustainability of healthcare systems.3 
Reports from the Institute of Medicine4 
and international studies have repeatedly 
demonstrated similar levels of low- value 
care.1 5–7
Recognition of the overuse of low- value 
care led to the establishment of Choosing 
Wisely (CW) by the American Board of 
Internal Medicine Foundation in 2012 
and subsequently spread to over 20 coun-
tries.8 CW is an initiative that seeks to 
encourage a dialogue between clinicians 
and patients about avoiding unnecessary 
medical tests, treatments and procedures 
in healthcare in order to ensure high- 
quality care and avoid harm.9 Initial 
efforts have focused on developing CW 
recommendations and measuring baseline 
rates of overuse10 and some local efforts 
to reduce low- value care. In the USA, 
over 80 partners have developed 550 
recommendations pertaining to unnec-
essary tests, treatments and procedures11 
and in Canada, over 70 medical specialty 
societies have developed more than 350 
recommendations.12 Similar efforts have 
been planned or launched in Germany, 
Austria, Australia, New Zealand, England, 
Wales, Italy, Netherlands, Norway, 
Portugal, France, Israel, Brazil and Japan 
with other countries planning or in early 
stages of launching national campaigns. 
Internationally, CW leaders from existing 
or planned national CW campaigns meet 
yearly to discuss implementation of the 
recommendations in their respective 
countries and collectively have formed a 
collaborative learning community.13
Despite such clear uptake of and enthu-
siasm in the CW initiative and some early 
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successes in lowering low- value care through local 
interventions,10 14 studies have shown limited large- 
scale change in ordering rates of low- value care since 
the launch of these campaigns.15 16 The issue of imple-
menting CW recommendations and evaluating the 
effects of these recommendations has received much 
less attention. Recommendations alone will not change 
practice.17 18 Recent commentaries have suggested that 
the focus of the campaign should be on identifying and 
applying evidence- based strategies to effectively reduce 
low- value care.13 19 There is substantial evidence and 
guidance on how to implement evidence- based strat-
egies. However, few conceptual frameworks exist 
to guide de- implementation, and those that do exist 
focus on team culture or organisational change20 or 
target change in a specific clinical setting,21 making it 
difficult to generalise the frameworks across a myriad 
of healthcare settings and contexts.
What is de-implementation?
Broad definitions of implementation and de- imple-
mentation exist in healthcare. The National Institute 
of Health defined implementation as “the use of strat-
egies to introduce or change evidence- based health 
interventions within specific settings”22 whereas 
de- implementation in the healthcare context has been 
defined as the “abandonment of medical practices or 
interventions that have been found to be ineffective 
and harmful”.23 Developing theory and evidence to 
support de- implementation interventions is of signif-
icant importance for healthcare systems.
While evidence exists about how to implement 
evidence- based practices in general and some inter-
ventions are reported as generally effective (eg, audit 
and feedback,24 academic detailing25), there has been 
less attention focused on the problem of implementing 
recommendations to reduce low- value healthcare. 
Further research is needed to explore the generalis-
ability of research findings about general implemen-
tation activities that aim that to reduce low- value 
healthcare.
using behavioural approaches to inform de-
implementation efforts
De- implementation interventions can be delivered 
at any level within the healthcare system: from the 
individual health professional, healthcare groups or 
teams, organisations providing healthcare, up to and 
including the larger healthcare system.26 Successful 
interventions (whether implementation or de- imple-
mentation) require key actors (patients, healthcare 
providers, managers and policy- makers) to change 
their behaviours and/or decisions while working in the 
complex (ordered chaos) of healthcare environments. 
Interventions to translate evidence into practice 
can be effective with the application of behavioural 
approaches.27–29 While behavioural theories, for the 
most part, do not distinguish between implementation 
and de- implementation, techniques grounded in 
psychology can specifically target de- implementation 
(eg, behavioural substitution).30 31 Evidence and theory 
from behavioural science have informed methods for 
identifying factors that explain and influence behav-
iour, selection of techniques to address the barriers, 
and guidance about reporting behaviour change 
interventions.29 31–34 These approaches have yet to 
be explicitly applied in a systematic and theory- based 
manner to inform interventions for reducing low- 
value care. The current paper addresses this gap by 
presenting the Choosing Wisely De- Implementation 
Framework (CWDIF; figure 1), informed by state- 
of- the- art approaches from implementation science 
to develop and evaluate interventions to reduce low- 
value care.
choosIng WIsely de-ImplementAtIon 
FrAmeWork
French and colleagues29 proposed a process to develop 
theory- informed interventions to change health-
care professional behaviour involving four key steps: 
Who needs to do what differently?; Using a theoret-
ical framework, what barriers and enablers need to 
be addressed?; What intervention components could 
overcome the modifiable barrier and enhance the 
enablers?; How will we measure behaviour change?.
The CWDIF builds on the French model29 and 
uses tools from behavioural science (eg, Theoret-
ical Domains Framework and behaviour change 
matrix)31 33 35 to present a systematic framework to 
develop, evaluate and scale up de- implementation 
interventions. The CWDIF is not a health system–
specific, or country- specific, framework and can be 
used by any initiatives to systematically and rigorously 
identify better de- implementation strategies to reduce 
low- value care. Currently, the CWDIF is being applied 
to de- implement two CWC recommendations (preop-
erative tests and imaging for low back pain) in three 
Canadian provinces with differing healthcare systems 
(work on- going; protocol manuscript in preparation) 
and included in a European Union funding call to 
reduce low- value care in four countries. As a concrete 
exemplar, we present our on- going work with the 
CWDIF to reduce low- value care in Canada: unnec-
essary preoperative testing for low- risk surgical proce-
dures (see box 1).
phase 0: identification of potential areas of low-value 
healthcare
Recognition that overuse is a real issue is an essential 
step in the framework and engaging with decision- 
makers and healthcare providers about the impor-
tance of the overuse issue is critical. International 
programmes such as the CW campaign,8 9 36 Preventing 
Overdiagnosis initiative37 as well as the BMJ Too 
Much Medicine38 39 have helped illustrate that overuse 
in medicine and low- value care is a problem facing 
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Figure 1 Choosing Wisely De- Implementation Framework with preoperative testing example.
many countries and that ways to target these problems 
need to be developed. We found that engaging with 
medical societies to develop a process for members to 
actively contribute to the identification of low- value 
practices in their own discipline was successful. For 
example, the Canadian Anaesthesiologists’ Society in 
partnership with CW Canada released a list of five 
recommendations related to preoperative testing (see 
box 1; Phase 0).40 Specifically, routine preoperative 
testing should be avoided in specific surgical popula-
tions where these tests provide no benefit or potential 
harm such as complications from unnecessary delays 
or invasive follow- up testing for false- positives.40 41 
The remaining Phases outline a framework for moving 
the recommendations into practice behaviour.
phase 1: identification of local priorities for 
implementation of cW recommendations
We recommend that healthcare systems and organisa-
tions identify their own local priorities about which 
CW recommendations they should implement, as it is 
not feasible to address all identified recommendations 
simultaneously. Such decisions should be informed by 
empirical studies demonstrating overuse of low- value 
tests and/or significant variations in practice; and/or 
consensus processes involving key local stakeholders 
where evidence around the priority, stakeholder 
engagement and professional agreement that the 
priority is important are discussed. In the Ontario 
example, both empirical data (hospital administra-
tive data) and a consensus approach (a meeting of key 
hospital leaders) identified local priorities (see box 1; 
Phase 1). We suggest using local administrative data 
if available, and stakeholder engagement to identify 
priorities for implementation based on the empir-
ical data, evidence of lack of benefit, professional 
consensus, variation and/or suboptimal levels of clin-
ical performance.
phase 2: identification of barriers and enablers to 
implementing cW recommendations and potential 
interventions to overcome these
Reducing low- value healthcare will require numerous 
stakeholders to change their behaviours, the largest 
stakeholder group being healthcare professionals.29 
There is increasing recognition of the value of behav-
ioural theories and concepts to identify barriers to 
implementation and potential interventions to over-
come them.42 Adopting a behavioural approach to 
implementation broadens the theories, methods and 
tools available to promote implementation. In addi-
tion, behavioural theories can help investigate main 
Protected by copyright.
 o
n
 February 10, 2020 at Universitaetsbibliothek Bern.
http://qualitysafety.bmj.com/
BM
J Qual Saf: first published as 10.1136/bmjqs-2019-010060 on 6 February 2020. Downloaded from 
4 Grimshaw JM, et al. BMJ Qual Saf 2020;0:1–9. doi:10.1136/bmjqs-2019-010060
Research and reporting methodology
Box 1 Application of the CWDIF: unnecessary 
preoperative testing
Many preoperative tests are routinely ordered for 
apparently healthy patients undergoing low- risk surgery 
without any clinical indication, and the subsequent test 
results are rarely used. In addition, unnecessary testing 
may lead physicians to pursue and treat borderline and 
false- positive laboratory abnormalities.
Phase 0: identification of potential areas of low- value 
healthcare
The Canadian Anaesthesiologists’ Society has 
established its Top 5 CWC recommendations, which 
focus on low- value tests in ambulatory surgery. They 
recommend that investigations should not be ordered 
on a routine basis, but should be based on the patient’s 
health status, drug therapy and with consideration to the 
proposed surgical intervention.
Phase 1: identification of local priorities for 
implementation of CWC recommendations
Using administrative data from the Institute of 
Clinical Evaluative Sciences, a population- based study 
demonstrated overuse of low- value tests and a significant 
interhospital variation across 137 Ontario hospitals.2 For 
example, 31% of patients received an ECG with 26- fold 
variation in Ontario hospitals.2 Key health system leaders 
met to identify CW Ontario priorities for implementation; 
a key initial hospital priority was preoperative testing 
prior to ambulatory surgery.
Phase 2: identification of barriers to implementing 
CWC recommendations and potential interventions to 
overcome these
A Theoretical Domains Framework (TDF) study with 
Ontario anaesthesiologists and surgeons identified key 
beliefs associated with overuse of preoperative tests.59 
Findings included conflicting comments about who was 
responsible for the test ordering (TDF domain—Social/
professional role and identity), inability to cancel tests 
ordered by fellow physicians (Beliefs about capabilities 
and Social influences) and the problem with tests being 
completed before the anaesthesiologists see the patient 
(Beliefs about capabilities and Environmental context 
and resources). There were also concerns that not testing 
might be associated with harms (overnight admissions, 
re- admissions). Findings from the TDF study led to the 
development of a pilot intervention, which focused on 
increasing accountability in the healthcare system for 
preoperative test ordering (publication in preparation).
Phase 3: evaluation of CWC implementation programmes
Our pilot study in one hospital of the proposed 
intervention led to a 48% reduction in low- value 
preoperative ECGs. We are currently conducting a 
parallel two- arm cluster randomised control trial with 
repeated cross- sectional measurements before and after 
intervention in 22 Ontario hospitals. Our intervention 
Continued
Box 1 Continued
will focus on increasing accountability in the healthcare 
system for preoperative test ordering.
Phase 4: spread of effective CWC implementation 
programmes
Plans for spread of the successful intervention will 
include the development of a multi- jurisdictional learning 
platform for the sharing of methods and tools developed 
as well as training support for region to implement the 
intervention.
effects, mediators (mechanisms) and moderators (effect 
modifiers) between behavioural influences and inter-
ventions in the environments (policy, system, organisa-
tion, team)43 in which healthcare professionals work. 
The options for which theories to use can be over-
whelming and certain theories may be better suited to 
different units of practice, such as individuals, groups 
and organisations. The Theoretical Domains Frame-
work (TDF) may be one option for researchers who 
are unsure about which theory to select to use. The 
TDF is a comprehensive behavioural framework based 
on 128 constructs from 33 psychological theories to 
identify barriers and has been widely used to identify 
determinants of targeted behaviours.33 35
The TDF33 consists of 14 domains: Knowledge, 
Skills, Beliefs about consequences, Beliefs about capa-
bilities, Optimism, Social, professional role and iden-
tity, Intention, Goals, Memory/attention/decision 
processes, Environmental context and resources, Social 
influences, Emotions, Behavioural regulation and 
Reinforcement (see table 1 for explanation of the TDF 
domains).35 44 45 The TDF was designed to be adapted 
to any behavioural context under investigation and 
increasingly has been used to investigate determinants 
of behaviours of both healthcare professionals and 
patients.46 These determinants, or beliefs, within each 
theoretical domain can then be addressed by imple-
mentation techniques and strategies in an intervention.
Each intervention designed to address a CW recom-
mendation will have certain assumptions and condi-
tions that need to be considered and addressed for the 
intervention to be most effective. We recommend that 
the choice of improvement programme or interven-
tion be based on a number of criteria: (1) diagnostic 
assessment of theory- informed barriers and enablers; 
(2) understanding the mechanism of action of inter-
vention components designed to address the barriers; 
(3) empirical evidence about effects of intervention 
components; (4) available resources to intervention 
developers; (5) practical and logistical issues within the 
context of the healthcare setting. The first three criteria 
are based on the findings from barriers assessment of 
phase 2 and are grounded in behavioural sciences46 
and the last two criteria are based in the practicali-
ties of working in a resource- constrained and complex 
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Table 1 TDF domains and their explanations (reprinted with permissions from Cheung et al44 and Patey et al45)
Domain Description
Knowledge Existing procedural knowledge, knowledge about guidelines, knowledge about evidence and how that influences what the 
participants do
Skills Competence and ability about the procedural techniques required to perform the behaviour
Social/professional role 
and identity
Boundaries between professional groups (ie, is the behaviour something the participant is supposed to do or someone else’s 
role?)
Beliefs about 
capabilities
Perceptions about competence and confidence in doing the behaviour and how that influences their behaviour
Optimism Whether the participant’s optimism or pessimism about the behaviour influences what they do
Beliefs about 
consequences
Perceptions about outcomes, advantages and disadvantages of performing the behaviour and how that influences whether they 
perform the behaviour
Reinforcement Previous experiences that have influenced whether or not the behaviour is performed
Intention A conscious decision to perform a behaviour or a resolve to act in a certain way
Goals Priorities, importance, commitment to a certain course of actions or behaviours
Memory, attention and 
decision processes
Attention control, decision- making, memory (ie, is the target behaviour problematic because people simply forget?)
Environmental context 
and resources
How factors related to the setting in which the behaviour is performed (eg, people, organisational, cultural, political, physical and 
financial factors) influence the behaviour
Social influences External influence from people or groups to perform or not perform the behaviour
How the views of colleagues, other professions, patients and families, and doing what you are told, influence the behaviour
Emotion How feelings or affect (positive or negative) may influence the behaviour
Behavioural regulation Ways of doing things that relate to pursuing and achieving desired goals, standards or targets
Strategies the participants have in place to help them perform the behaviour
Strategies the participants would like to have in place to help them
environment.47 When designing interventions, we 
recommend that readers consider what the best inter-
vention components or behaviour change techniques31 
used to address the barriers may be, the appropriate 
method of delivery of those intervention components 
as well as how the components will be operationalised 
in the interventions. By systematically addressing these 
issues in a theory- informed manner and identifying 
the most appropriate behaviour change techniques or 
intervention components to specifically target barriers 
identified, we increase the likelihood that the designed 
intervention will change the behaviour.
phase 3: evaluation of cW implementation 
programmes
Given the relative lack of attention that has been paid 
to reducing low- value healthcare programmes, it is 
important to evaluate any new initiatives to generate 
knowledge about the effects of such programmes 
and how they work. In general, cluster randomised 
controlled trials (or well- designed quasi- experimental 
studies) are the gold standard for evaluating 
programmes.48 However, trial results tell us whether 
an intervention was effective but not how and why the 
intervention was effective. In the absence of a theoret-
ical underpinning, it may be difficult to interpret posi-
tive or negative effects of interventions or the failure 
of an intervention to bring about change.47
One may want to consider using a range of 
approaches to enhance the informativeness and value of 
evaluations including fidelity substudies (to determine 
whether the content of interventions was delivered 
as designed), mechanistic substudies (theory- based 
process evaluations to determine whether our inter-
ventions activated the hypothesised mediating path-
ways, and if so, was this sufficient to lead to practice 
change),49 qualitative process evaluations (to under-
stand participants’ experiences of being in a trial)50 51 
or exploratory statistical analyses (eg, subgroup anal-
yses and hierarchical regressions to explore the effects 
of interventions across different contexts and gender 
and equity gradients). In addition, given the limited 
resources for health, it is also crucial to assess the value 
for money of such de- implementation programmes. 
Economic evaluation provides a useful framework to 
inform de- implementation decisions because it can 
synthesise data from various sources, provide explicit 
estimates of long- term costs and benefits of alterna-
tive de- implementation programmes and address the 
uncertainty around costs and benefits as well as the 
decision- maker’s dilemma. It is recommended that 
these substudies should be decided on a priori and 
include pre- planned protocols.
phase 4: spread of effective cW implementation 
programmes
During Phases 1–3, particular attention should be 
paid to ensuring scaling up and sustainability of inter-
ventions to increase the likelihood of wider spread. 
Providing detailed implementation packages to health-
care system partners (including professional groups) 
responsible for this phase is imperative to ensure 
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dissemination of the research findings and the poten-
tial for replication in other systems and regions.8 13 We 
recommend engagement with knowledge users and 
other stakeholders throughout all phases of the frame-
work which will assist in the final phase. The goal of 
this phase is to spark insight and discussion on findings 
and future approaches for scale- up and spread of effec-
tive interventions and generate thinking and action by 
those participating in this phase.
dIscussIon
In this paper, we present a ‘how- to’ framework for any 
organisation to follow to de- implement low- value care 
in a systematic and rigorous manner. In addition, we 
provide a working example of the CWDIF to reduce 
low- value preoperative tests for low- risk ambulatory 
surgeries, to illustrate the utility of the framework and 
further contribute to the evidence base on de- imple-
mentation.
There are a wide range of de- implementation strat-
egies available but no ‘magic bullet’ or ideal interven-
tion to be used across all de- implementation initiatives. 
Evidence shows that all available strategies work some 
of the time but none work all the time, the observed 
effects are often modest and it is not always clear why 
this is the case.52–54 Despite increasing policy interest 
in de- implementation, with international programmes 
such as the Choosing Wisely campaign,8 9 relatively 
little has been reported that elucidates and addresses 
systematic methods for designing de- implementation 
interventions.30 It is likely that de- implementation will 
involve different strategies than those used for imple-
mentation, but there is little evidence to indicate what 
they may be.18 39 The CWDIF can be used to iden-
tify and evaluate the most effective approaches to 
de- implementation.
There are other frameworks that address de- im-
plementation but either focus on a specific change 
strategy20 or clinical setting,21 or are broad in scope.55 
For example, Ellen and colleagues55 provide a broad 
framework for understanding and addressing overuse 
from a broad lens, recognising that de- implementa-
tion interventions may target system, policy, hospital, 
practice, provider and patient levels. They explicitly 
recognise the importance of ensuring that de- im-
plementation strategies (at whatever level) lead to 
provider (and patient) behaviour change but provide 
little practical guidance on how to design de- imple-
mentation interventions likely to result in behaviour 
change. The CWDIF addresses this gap by building on 
advances in behavioural and implementation science 
to provide a stepwise theory- driven approach to 
designing (and evaluating) de- implementation strate-
gies. Specifically, the CWDIF incorporates behavioural 
and implementation science methods for identifying 
factors that explain and influence behaviour,33 35 56 
and selecting behaviour change strategies57 to address 
identified barriers. While these approaches have been 
used widely in implementation science (eg, there are 
over 800 peer- reviewed publications using the TDF 
to change health professional behaviour,46 they have 
(with few exceptions58) been used less often to reduce 
low- value care.
The key challenge for de- implementation research, 
as for implementation research, is identifying ‘what 
interventions work for whom and under what circum-
stances’. Implementation science models highlight 
the importance of developing strategies based on an 
understanding of the likely barriers and enablers to 
care. This suggests that the effectiveness of implemen-
tation strategies is likely a function of the validity and 
comprehensiveness of the barrier and enabler assess-
ment, the mapping of effective intervention compo-
nents to address the identified barriers and enablers, 
the fidelity of intervention delivery and the absence 
of unrecognised contextual factors that might modify 
the effects of an intervention. The CWDIF provides 
a clear process for individuals to consider each of 
these factors and proposes tools and methods one 
may consider using to address them. To better under-
stand ‘what interventions work for whom and under 
what circumstances’, essential elements of evaluations 
should include careful contextualised implementation 
strategy development, which builds on theory and 
existing knowledge and identifies potential barriers 
and intervention components that activate mediating 
mechanisms to overcome the identified barriers.
CW began as a grassroots movement to promote 
dialogue between doctors and their patients about low- 
value care and to ensure delivery of high- quality neces-
sary medical care. The next challenge faced by CW 
is to develop robust approaches to support de- imple-
mentation of CW identified low- value care. While CW 
campaigns in many countries have actively engaged 
clinicians and patients in identifying and reducing 
low- value care, successfully de- implementing unnec-
essary services requires attention to both factors that 
perpetuate performance of overuse and the barriers 
to their reduction. Kerr et al recently summarised 
the initial experience of CW campaigns and noted 
that ‘Making greater inroads in reducing the use of 
low- value care will necessitate developing new ways 
to address perceived barriers’ to de- implementation’ 
involving the development of ‘theory- based multi-
level interventions that simultaneously decrease the 
use of low- value care and preserve the use of appro-
priate care’ and ‘rigorous and pragmatic approaches 
to test, implement, and evaluate these interventions’.19 
The CWDIF provides a systematic process grounded 
in behaviour sciences and methodological rigour to 
guide the de- implementation of low- value healthcare 
services.
conclusIons
This paper presents a stepwise theory- based frame-
work for de- implementing low- value care identified 
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through CW recommendations for reducing low- 
value care. It is essential that efforts to implement 
CW recommendations use current state- of- the- science 
approaches and methods from implementation science 
and that healthcare systems maximally learn from 
implementation initiatives to avoid unnecessary dupli-
cation of effort and waste. In recognition of this need, 
CW Canada and the international CW campaigns are 
committed to developing implementation research 
networks to establish a learning healthcare system to 
support de- implementation of low- value care identi-
fied in CW recommendations. This framework offers 
opportunities for essential proof of concepts and can 
evaluate the feasibility of multi- jurisdictional shared 
programmes of implementation research in areas of 
common interest.
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